Related Experiment Video

Updated: Jun 8, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.9K

Corrigendum: Transcranial magnetic stimulation and ketamine: implications for combined treatment in depression

Weronika Dębowska1, Magdalena Więdłocha1,2, Marta Dębowska1

  • 1Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland.

Frontiers in Neuroscience
|November 8, 2024
PubMed

Abstract:

[This corrects the article DOI: 10.3389/fnins.2023.1267647.].

Keywords:
TMScombined TMS and ketaminedepressive disordersketamineneuroplasticityrTMStranscranial magnetic stimulationtreatment-resistant depression

More Related Videos

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil
09:30

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil

Published on: October 4, 2016

22.2K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K

Related Experiment Videos

Last Updated: Jun 8, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.9K
Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil
09:30

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil

Published on: October 4, 2016

22.2K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25

Articles linked to this work by shared authors, journal, and citation graph.

Co-occurrence of dissociation and anxiety and depressive disorders in adults: a scoping review.

Frontiers in psychiatry·2026

Dissociative symptom trajectories during treatment with selective serotonin reuptake inhibitors for depressive or anxiety disorders.

BMC psychiatry·2026

Dissociative symptoms in depressive and anxiety disorders: prevalence and clinical correlates in a real-world outpatient sample.

Journal of psychiatric research·2026

Expert group recommendations on the use of antipsychotic drugs in patients with somatic diseases. Part I: (metabolic syndrome, cardiovascular diseases).

Psychiatria polska·2026

Expert group recommendations on the use of antipsychotic drugs in patients with somatic diseases. Part II: renal failure, liver failure, neurological diseases.

Psychiatria polska·2026

Genetics and Neurobiology of Treatment-Resistant Depression-A Review.

International journal of molecular sciences·2025

GLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease.

Frontiers in neuroscience·2026

Bioinformatics-based identification of potential genes in the thalamus associated with chronic orofacial and somatic inflammatory pain.

Frontiers in neuroscience·2026

Retinal neurovascular coupling dysfunction and plasma metabolomic features as biomarkers of Alzheimer's disease: an integrated diagnostic model.

Frontiers in neuroscience·2026

Biomarkers of perioperative neurocognitive disorders after cardiac surgery: from mechanistic insights to clinical translation.

Frontiers in neuroscience·2026

Incomplete binaural restoration in single-sided deafness treated with cochlear implants: insights from compensatory head-orienting behaviors.

Frontiers in neuroscience·2026

Establishing reliable neural health measures in adult cochlear implant users.

Frontiers in neuroscience·2026

[Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Intrathecal immunoglobulin administration for refractory viral central nervous system infection after allogeneic hematopoietic stem cell transplantation].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B.

Journal of the American College of Cardiology·2026

Gene Silencer Therapy in Transthyretin Amyloid Cardiomyopathy: A Meta-Analysis of Outcomes Trials.

JAMA·2026

Advanced therapy medicinal products in Saudi Arabia: Regulation and development.

Regenerative therapy·2026

289th ENMC international workshop: assessing and managing emerging AAV related toxicities after gene therapy for neuromuscular disorders, 26 - 28 September 2025, Hoofddorp, The Netherlands.

Neuromuscular disorders : NMD·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us